77 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Aminoquinazoline compounds as A2A antagonist
Merck Sharp & Dohme
Aminopyrimidine derivatives for use as modulators of kinase activity
Merck Patent
Resorcinol derivative as HSP90 inhibitor
Chia Tai Tianqing Pharmaceutical Group
Quinazoline scaffold based compounds, pharmaceutical compositions and methods of use thereof
Technion Research & Development Foundation
Substituted triazolopyridines and methods of use thereof
Genentech
Cyclic sulfonamides as sodium channel blockers
Purdue Pharma
Compositions, methods, and systems for the synthesis and use of imaging agents
Lantheus Medical Imaging
Androgen receptor antagonists
University of California
Tetrahydro-benzodiazepinones
Hoffmann-La Roche
Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
Amgen
Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors
Tolero Pharmaceuticals
Imidazolone derivatives, pharmaceutical compositions and uses thereof
Beijing Forelandpharma
Histone deacetylase inhibitors and compositions and methods of use thereof
Chdi Foundation
Tetrazole derivatives and their use as potassium channel modulators
Saniona
Kinase modulating compounds, compositions containing the same and use thereof
Centaurus Biopharma
Cannabinoid-2 agonists
Allergan
Small molecule myristate inhibitors of Bcr-abl and methods of use
Dana-Farber Cancer Institute
Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor
East China University of Science and Technology
Inhibitors of PI3K-delta and methods of their use and manufacture
Exelixis
Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders
Janssen Pharmaceutica
Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
Cayman Chemical
BET bromodomain inhibitors and therapeutic methods using the same
The Regents of The University of Michigan
PRMT5 inhibitors and uses thereof
Epizyme
Substituted thiazolopyrimidines
Bayer Pharma Aktiengesellschaft
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Bristol-Myers Squibb
Compositions useful for treating disorders related to kit
Blueprint Medicines
Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases
Abbvie Deutschland
Tyrosine kinase inhibitors
Principia Biopharma
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
Novartis
Oxazolidinones as modulators of mGluR5
Bristol-Myers Squibb
Modulators of fatty acid amide hydrolase
Janssen Pharmaceutica
Substituted pyrroles active as kinases inhibitors
Nerviano Medical Sciences
Substituted naphthyridine and quinoline compounds as MAO inhibitors
Dart Neuroscience (Cayman)
Arylpyrrolopyridine derived compounds as LRRK2 inhibitors
H. Lundbeck
Opioid agonists and uses thereof
Nektar Therapeutics
Indole carboxamide compounds
Bristol-Myers Squibb
Anti-fibrotic pyridinones
Intermune
Methods for treating seizure disorders and pain
University of California
Inhibitors of indoleamine 2,3-dioxygenase (IDO)
Bristol-Myers Squibb
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
SRMLSC
Triazine derivative and pharmaceutical composition comprising the same
Shionogi
Substituted pyrazines as GPR40 agonists
Janssen Pharmaceutica
Quinuclidine derivatives and medicinal compositions containing the same
Almirall
Amino-substituted isothiazoles
Bayer Pharma Aktiengesellschaft
BMP inhibitors and methods of use thereof
The Brigham and Women'S Hospital
Protein kinase C inhibitors and uses thereof
Rigel Pharmaceuticals
Positive allosteric modulators of mGluR2
Bristol-Myers Squibb
1,2,5-Substituted benzimidazoles as flap modulators
Janssen Pharmaceutica
Phthalazinone compounds and methods for the treatment of cystic fibrosis
Flatley Discovery Lab
Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof
Novartis
Kappa opioid ligands
The Scripps Research Institute
Fumagillol heterocyclic compounds and methods of making and using same
Zafgen
Pyridine derivatives as soft rock inhibitors
Redx Pharma
Quinazoline derivative
Carna Biosciences
Ethynyl derivatives
Hoffmann-La Roche
Bisaryl-bonded aryltriazolones and use thereof
Bayer Intellectual Property
Amide compounds, compositions and applications thereof
Advinus Therapeutics
Combination of kinase inhibitors and uses thereof
Intellikine
Indazole derivatives useful as CB-1 inverse agonists
Janssen Pharmaceutica
Heterocyclic ITK inhibitors for treating inflammation and cancer
Confluence Life Sciences
Glycosidase inhibitors and uses thereof
Alectos Therapeutics
Benzoxazinone derivatives for treatment of skin diseases
Sixera Pharma
Synthetic methods for spiro-oxindole compounds
Xenon Pharmaceuticals
Substituted 7-azabicycles and their use as orexin receptor modulators
Janssen Pharmaceutica
Hydroximic acid derivatives and medical applications therof
Double Rider Medicine
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
Incyte
Substituted imidazo[1,5-a]pyrazines as CGRP receptor antagonists
Bristol-Myers Squibb
Inhibitor of breast cancer resistance protein (BCRP)
Millennium Pharmaceuticals
Biaryl amide compounds as kinase inhibitors
Novartis
Methods for the treatment of locally advanced breast cancer
Celgene
Pyrazol derivatives
Hoffmann-La Roche
Substituted pyrazolopyrimidines as kinases inhibitors
Jiangsu Medolution
Synthesis and anti-HIV-1 activity of thio analogues of dihydroalkoxybenzyloxopyrimidines.
Sapienza University of Rome
Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series.
Sapienza University of Rome
Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.
Boehringer Ingelheim (Canada)
Aminodiol HIV protease inhibitors. Synthesis and structure-activity relationships of P1/P1' compounds: correlation between lipophilicity and cytotoxicity.
Bristol-Myers Squibb
Synthesis and structure-activity relationships of a series of penicillin-derived HIV proteinase inhibitors containing a stereochemically unique peptide isostere.
Glaxo Group Research